Susan Schneider, MD
Senior Vice President of Ophthalmology Clinical Development
Susan Schneider, MD, serves as Senior Vice President, Ophthalmology Clinical Development for Ji Xing Pharmaceuticals. In this role, Susan is responsible for overseeing the Company’s ophthalmology strategy and clinical development.
Prior to joining Ji Xing Pharmaceuticals, Susan served as Senior Vice President of Ophthalmology Clinical Development at Eloxx Pharmaceuticals. Susan also held positions as Chief Medical Officer at ThromboGenics (now Oxurion), Vice President and Therapeutic Area Head of Retina and Glaucoma at Allergan, Vice President Retina, at Acucela, Sr. Medical Director at GlaxoSmithKline, Director, Clinical and Scientific Affairs for Ophthalmology at Bausch & Lomb, Vice President, US Clinical Affairs and Chief Medical Officer at Santen, and Medical Director at Genentech. While at Genentech, she worked extensively on the ranibizumab program.
Dr. Schneider received her medical degree from the Medical College of Pennsylvania followed by a residency in ophthalmology at the Medical College of Virginia. She completed fellowship training in ocular oncology at Thomas Jefferson Wills Eye Hospital and in ophthalmic pathology at The Johns Hopkins Wilmer Eye Institute.